BRCA2 and ductal breast carcinoma in situ: IDC shows significant overlap with DCIS in several aspects, including epidemiological risk factors such as age and family history, genetic factors such as BRCA1/BRCA2, and molecular markers such as ER, PR, and HER2 (6).